Trial Profile
Phase I, Single Centre, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 After a Single Ascending Bolus Dose Followed by a Single Infusion Dose in Elderly (=65 Years) Healthy Volunteers.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2012
Price :
$35
*
At a glance
- Drugs AZD 3043 (Primary)
- Indications Perioperative pain
- Focus Adverse reactions
- 15 Feb 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 18 Mar 2010 New trial record